(Q36583383)

15 August 2017

Randomized clinical trial of the iron-based phosphate binder PA21 in hemodialysis patients (English)

1 reference

15 August 2017

3

Adrian Covic

1 reference

15 August 2017

Rudolf P Wüthrich

1

1 reference

15 August 2017

Michel Chonchol

2

1 reference

15 August 2017

Sylvain Gaillard

4

1 reference

15 August 2017

Edward Chong

5

1 reference

15 August 2017

James A Tumlin

6

1 reference

15 August 2017

2 November 2012

1 reference

Clinical Journal of the American Society of Nephrology

15 August 2017

1 reference

15 August 2017

8

1 reference

15 August 2017

2

1 reference

15 August 2017

280-289

1 reference

Clinical pharmacokinetics of the phosphate binder lanthanum carbonate

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562865

Control of hyperphosphatemia among patients with ESRD.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562865

Phosphate binding therapy in dialysis patients: focus on lanthanum carbonate.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562865

Absolute bioavailability and disposition of lanthanum in healthy human subjects administered lanthanum carbonate.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562865

Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562865

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562865

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562865

PA21: a novel phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease

20 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23124782

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23124782

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2215/CJN.08230811

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

23124782

1 reference